Ketamine Versus Dexmedetomidine in Supraclavicular Brachial Plexus Block

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

April 21, 2019

Primary Completion Date

December 28, 2020

Study Completion Date

December 30, 2020

Conditions
Supraclavicular Brachial Plexus Block
Interventions
DRUG

Supraclavicular Brachial Plexus Block with bupivacaine

"drug: 20 ml 0.5%bupivacaine plus 20 ml 0.9% normal saline is administered around the brachial plexus on the operative side Drug: IM diclofenac sodium (75 mg amp) is injected if VAS more than 4.~Device: ultrasound-guided supraclavicular Brachial Plexus nerve block"

DRUG

Supraclavicular Brachial Plexus Block with Ketamine

"drug: 20 ml 0.5%bupivacaine, 20 ml 0.9% normal saline plus 1mg\\kg ketamine is administered around the brachial plexus on the operative side Drug: IM diclofenac sodium (75 mg amp) is injected if VAS more than 4.~Device: ultrasound-guided supraclavicular Brachial Plexus nerve block"

DRUG

Supraclavicular Brachial Plexus Block with Dexmedetomidine

"drug: 20 ml 0.5%bupivacaine, 20 ml 0.9% normal saline plus 1µg\\kg dexmedetomidine is administered around the brachial plexus on the operative side Drug: IM diclofenac sodium (75 mg amp) is injected if VAS more than 4.~Device: ultrasound-guided supraclavicular Brachial Plexus nerve block"

Trial Locations (1)

61519

Minya University, Minya

All Listed Sponsors
lead

Minia University

OTHER

NCT04508894 - Ketamine Versus Dexmedetomidine in Supraclavicular Brachial Plexus Block | Biotech Hunter | Biotech Hunter